These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 7924138)
21. Correction of a mineralization defect by overexpression of a wild-type cDNA for COL1A1 in marrow stromal cells (MSCs) from a patient with osteogenesis imperfecta: a strategy for rescuing mutations that produce dominant-negative protein defects. Pochampally RR; Horwitz EM; DiGirolamo CM; Stokes DS; Prockop DJ Gene Ther; 2005 Jul; 12(14):1119-25. PubMed ID: 15815702 [TBL] [Abstract][Full Text] [Related]
22. Mineral changes in a transgenic mouse model for osteogenesis imperfecta. Cassella JP; Pereira R; Prockop DJ; Ali SY Br J Biomed Sci; 1996 Jun; 53(2):108-15. PubMed ID: 8757687 [TBL] [Abstract][Full Text] [Related]
23. Association of COL1A1 and otosclerosis: evidence for a shared genetic etiology with mild osteogenesis imperfecta. McKenna MJ; Kristiansen AG; Bartley ML; Rogus JJ; Haines JL Am J Otol; 1998 Sep; 19(5):604-10. PubMed ID: 9752968 [TBL] [Abstract][Full Text] [Related]
24. Gene therapy approaches for osteogenesis imperfecta. Niyibizi C; Wang S; Mi Z; Robbins PD Gene Ther; 2004 Feb; 11(4):408-16. PubMed ID: 14724682 [TBL] [Abstract][Full Text] [Related]
25. Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations. Garnero P; Schott AM; Prockop D; Chevrel G Bone; 2009 Mar; 44(3):461-6. PubMed ID: 19071236 [TBL] [Abstract][Full Text] [Related]
26. Somatic cell mosaicism: another source of phenotypic heterogeneity in nuclear families with osteogenesis imperfecta. Constantinou-Deltas CD; Ladda RL; Prockop DJ Am J Med Genet; 1993 Jan; 45(2):246-51. PubMed ID: 8456810 [TBL] [Abstract][Full Text] [Related]
27. Chemical cleavage method for the detection of RNA base changes: experience in the application to collagen mutations in osteogenesis imperfecta. Bateman JF; Lamande SR; Hannagan M; Moeller I; Dahl HH; Cole WG Am J Med Genet; 1993 Jan; 45(2):233-40. PubMed ID: 8456808 [TBL] [Abstract][Full Text] [Related]
28. Increased expression of the gene for the pro alpha 1(IV) chain of basement-membrane procollagen in cultured skin fibroblasts from two variants of osteogenesis imperfecta. Pihlajaniemi T; McKeon J; Gay S; Gay R; de Wet WJ; Myers JC; Prockop DJ Biochem J; 1989 Jan; 257(2):439-45. PubMed ID: 2649075 [TBL] [Abstract][Full Text] [Related]
29. Osteogenesis imperfecta and its molecular diagnosis by determination of mutations of type I collagen genes. Tedeschi E; Antoniazzi F; Venturi G; Zamboni G; Tatò L Pediatr Endocrinol Rev; 2006 Sep; 4(1):40-6. PubMed ID: 17021582 [TBL] [Abstract][Full Text] [Related]
30. Severity of osteogenesis imperfecta and structure of a collagen-like peptide modeling a lethal mutation site. Radmer RJ; Klein TE Biochemistry; 2004 May; 43(18):5314-23. PubMed ID: 15122897 [TBL] [Abstract][Full Text] [Related]
31. Transgenic mice that express a mini-gene version of the human gene for type I procollagen (COL1A1) develop a phenotype resembling a lethal form of osteogenesis imperfecta. Khillan JS; Olsen AS; Kontusaari S; Sokolov B; Prockop DJ J Biol Chem; 1991 Dec; 266(34):23373-9. PubMed ID: 1744131 [TBL] [Abstract][Full Text] [Related]
32. [Attempts to use gene therapy for reducing connective tissue disorders--osteogenesis imperfecta]. Gajko-Galicka A Postepy Biochem; 2003; 49(1):18-25. PubMed ID: 14518394 [No Abstract] [Full Text] [Related]
33. Studies of otic capsule morphology and gene expression in the Mov13 mouse--an animal model of type I osteogenesis imperfecta. Stankovic KM; Kristiansen AG; Bizaki A; Lister M; Adams JC; McKenna MJ Audiol Neurootol; 2007; 12(5):334-43. PubMed ID: 17595534 [TBL] [Abstract][Full Text] [Related]
34. The Nicholas Andry Award-1996. The molecular pathology of osteogenesis imperfecta. Cole WG Clin Orthop Relat Res; 1997 Oct; (343):235-48. PubMed ID: 9345229 [TBL] [Abstract][Full Text] [Related]
35. Mutations linked to the pro alpha 2(I) collagen gene are responsible for several cases of osteogenesis imperfecta type I. Wallis G; Beighton P; Boyd C; Mathew CG J Med Genet; 1986 Oct; 23(5):411-6. PubMed ID: 3023615 [TBL] [Abstract][Full Text] [Related]
36. Nuclease S1 mapping of a homozygous mutation in the carboxyl-propeptide-coding region of the pro alpha 2(I) collagen gene in a patient with osteogenesis imperfecta. Dickson LA; Pihlajaniemi T; Deak S; Pope FM; Nicholls A; Prockop DJ; Myers JC Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4524-8. PubMed ID: 6087329 [TBL] [Abstract][Full Text] [Related]
37. Deficient expression of the small proteoglycan decorin in a case of severe/lethal osteogenesis imperfecta. Dyne KM; Valli M; Forlino A; Mottes M; Kresse H; Cetta G Am J Med Genet; 1996 May; 63(1):161-6. PubMed ID: 8723103 [TBL] [Abstract][Full Text] [Related]
38. Clinical variability of osteogenesis imperfecta linked to COL1A2 and associated with a structural defect in the type I collagen molecule. Superti-Furga A; Pistone F; Romano C; Steinmann B J Med Genet; 1989 Jun; 26(6):358-62. PubMed ID: 2567784 [TBL] [Abstract][Full Text] [Related]
39. Use of molecular haplotypes specific for the human pro alpha 2(I) collagen gene in linkage analysis of the mild autosomal dominant forms of osteogenesis imperfecta. Falk CT; Schwartz RC; Ramirez F; Tsipouras P Am J Hum Genet; 1986 Mar; 38(3):269-79. PubMed ID: 3006479 [TBL] [Abstract][Full Text] [Related]
40. Direct sequencing of PCR products derived from cDNAs for the pro alpha 1 and pro alpha 2 chains of type I procollagen as a screening method to detect mutations in patients with osteogenesis imperfecta. Zhuang J; Tromp G; Kuivaniemi H; Castells S; Bugge M; Prockop DJ Hum Mutat; 1996; 7(2):89-99. PubMed ID: 8829649 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]